Alma Health closes Series A round at US$10

Alma Health closes Series A round at US$10

The UAE-based direct-to-patient digital healthcare company Alma Health has raised US$10 million in a Series A funding round co-led by Knuru Capital and Hambro Perks Oryx Fund.

The fundraising round witnessed participation from e& Capital, S3 Ventures, Pinnacle Capital, and Khwarizmi Ventures, with KCP Capital acting as the financial advisor to the company, according to Forbes.

The company currently operates in the UAE, Saudi Arabia, and Egypt, and it plans to use the new funding to accelerate its growth in Saudi Arabia, enter new markets, and continue to hire top talent. 

It will also continue its mission to become one of the leading direct-to-patient healthcare providers specialized in chronic condition management.

Alma Health was established in 2021 by Tariq Seksek and Khaldoon Bushnaq, and it provides healthcare services to people with chronic conditions. It offers virtual doctor consultations directly via its application with one of the company’s licensed in-house physicians.

Alma Health is also offering at-home lab tests, automatic prescription renewals, and home delivery of prescription medicines without any additional cost.  

 Patients can also benefit from a second opinion on their chronic condition and a customized management plan to improve clinical outcomes.

If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.